Canada Inspection 81627 - Baxter Corporation - September 11, 2023

Canada Health Inspection 81627 for Baxter Corporation on September 11, 2023. Rating: C. Access full inspection details and violations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

Canada Health Inspection 81627 for Baxter Corporation on September 11, 2023. Rating: C. Access full inspection details and violations.

Violation Codes

C.02.006

C.02.007

C.02.008

C.02.009

C.02.010

C.02.011

C.02.012

C.02.013

C.02.014

C.02.015

C.02.020

C.02.021

C.02.022

C.02.023

C.02.024

C.02.029

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Baxter Corporation

Inspection Date

September 11, 2023

Product Type

drugs

ID: 76efe4f8-fcda-4bff-84a2-fe809c23b7cd

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox